CPT code 82677 represents a laboratory assay for estriol, a weak estrogen with clinical relevance primarily in pregnancy. The assay quantifies estriol levels to support maternal-fetal assessment and endocrine evaluation in prenatal care. Nationally, accurate coding and billing for hormone assays like 82677 affect laboratory workflows, claim adjudication, and prenatal testing panels.

Key payers typically involved in coverage decisions and reimbursement for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Payer-specific medical policies and coverage criteria can influence when the test is authorized and how it is reimbursed.

Readers will find concise information about the clinical context of the test, typical sites of service, and the kinds of benchmarks and policy considerations that commonly surround laboratory pregnancy-related assays. The publication provides an overview of billing practice implications, payer coverage landscape, and clinical relevance to prenatal care. Data not available in the input are noted where applicable.